Personalis, Inc. (PSNL) stock
PSNLNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30379% above fair value
$15.71−0.15 (-0.95%)
Close on Nov 13, 2026Market cap $1.68BP/E –Yield –
Personalis operating margin
Operating margin is operating income as a percentage of revenue.
Personalis's operating margin for the twelve months ending Sep 30, 2026 was -156.7%. For fiscal 2025 it was -126.4%, against -80.7% the year before. The highest annual figure on record is -34.4% in fiscal 2019.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -126.4% | −45.8 |
| FY2024 | Dec 31, 2024 | -80.7% | +68.9 |
| FY2023 | Dec 31, 2023 | -149.6% | +28.0 |
| FY2022 | Dec 31, 2022 | -177.6% | −101.2 |
| FY2021 | Dec 31, 2021 | -76.4% | −22.9 |
| FY2020 | Dec 31, 2020 | -53.6% | −19.2 |
| FY2019 | Dec 31, 2019 | -34.4% | +2.1 |
| FY2018 | Dec 31, 2018 | -36.5% | +199.5 |
| FY2017 | Dec 31, 2017 | -236.0% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -138.8% | +21.9 |
| Q2 FY2026 | Jun 30, 2026 | -150.2% | −23.5 |
| Q1 FY2026 | Mar 31, 2026 | -207.9% | −122.0 |
| Q4 FY2025 | Dec 31, 2025 | -145.7% | −37.9 |
| Q3 FY2025 | Sep 30, 2025 | -160.7% | −104.7 |
| Q2 FY2025 | Jun 30, 2025 | -126.7% | −51.9 |
| Q1 FY2025 | Mar 31, 2025 | -85.9% | +10.8 |
| Q4 FY2024 | Dec 31, 2024 | -107.8% | +14.0 |
| Q3 FY2024 | Sep 30, 2024 | -55.9% | +112.8 |
| Q2 FY2024 | Jun 30, 2024 | -74.8% | +77.0 |
| Q1 FY2024 | Mar 31, 2024 | -96.7% | +61.4 |
| Q4 FY2023 | Dec 31, 2023 | -121.8% | +70.0 |
| Q3 FY2023 | Sep 30, 2023 | -168.8% | +14.7 |
| Q2 FY2023 | Jun 30, 2023 | -151.8% | +1.1 |
| Q1 FY2023 | Mar 31, 2023 | -158.1% | +27.8 |
| Q4 FY2022 | Dec 31, 2022 | -191.9% | −94.1 |
| Q3 FY2022 | Sep 30, 2022 | -183.5% | −104.0 |
| Q2 FY2022 | Jun 30, 2022 | -152.9% | −83.9 |
| Q1 FY2022 | Mar 31, 2022 | -185.9% | −126.1 |
| Q4 FY2021 | Dec 31, 2021 | -97.8% | −31.5 |
| Q3 FY2021 | Sep 30, 2021 | -79.5% | −30.8 |
| Q2 FY2021 | Jun 30, 2021 | -69.0% | −20.3 |
| Q1 FY2021 | Mar 31, 2021 | -59.8% | −9.6 |
| Q4 FY2020 | Dec 31, 2020 | -66.3% | −26.6 |
| Q3 FY2020 | Sep 30, 2020 | -48.7% | −15.3 |
| Q2 FY2020 | Jun 30, 2020 | -48.7% | −23.1 |
| Q1 FY2020 | Mar 31, 2020 | -50.2% | −11.6 |
| Q4 FY2019 | Dec 31, 2019 | -39.6% | −15.7 |
| Q3 FY2019 | Sep 30, 2019 | -33.4% | −18.4 |
| Q2 FY2019 | Jun 30, 2019 | -25.7% | +16.5 |
| Q1 FY2019 | Mar 31, 2019 | -38.6% | – |
| Q4 FY2018 | Dec 31, 2018 | -23.9% | – |
| Q3 FY2018 | Sep 30, 2018 | -15.0% | – |
| Q2 FY2018 | Jun 30, 2018 | -42.1% | – |
See a number that looks wrong?